| | Other Issues: previous | next | latest | archiveCase Report Treatment with pioglitazone induced significant, reversible mitral regurgitation Mozhgan Dorkhan, Magnus Dencker, and Anders Frid PMCID: PMC2412844 Commentary Genetic and dietary salt contributors to insulin resistance in Dahl salt-sensitive (S) rats Marlene Shehata PMCID: PMC2365939 Hypothesis Are fish oil omega-3 long-chain fatty acids and their derivatives peroxisome proliferator-activated receptor agonists? Osman ABSM Gani PMCID: PMC2322958 Important genetic checkpoints for insulin resistance in salt-sensitive (S) Dahl rats Marlene F Shehata PMCID: PMC2459151 Are the adverse effects of glitazones linked to induced testosterone deficiency? M Carruthers, TR Trinick, E Jankowska, and AM Traish PMCID: PMC2576082 Methodology On the use of a continuous metabolic syndrome score in pediatric research Joey C Eisenmann PMCID: PMC2430947 Original Investigations Metabolic syndrome is not associated with reduction in aortic distensibility in subjects with type 2 diabetes mellitus Nicholas Tentolouris, Athanasia Papazafiropoulou, Ioannis Moyssakis, Stavros Liatis, Despoina Perrea, Maria Kostakis, and Nicholas Katsilambros PMCID: PMC2235836 Diacylglycerol kinase ζ inhibits myocardial atrophy and restores cardiac dysfunction in streptozotocin-induced diabetes mellitus Olga Bilim, Yasuchika Takeishi, Tatsuro Kitahara, Takanori Arimoto, Takeshi Niizeki, Toshiki Sasaki, Kaoru Goto, and Isao Kubota PMCID: PMC2265681 Rosiglitazone but not losartan prevents Nrf-2 dependent CD36 gene expression up-regulation in an in vivo atherosclerosis model Y Hernandez-Trujillo, F Rodriguez-Esparragon, A Macias-Reyes, A Caballero-Hidalgo, and Jose C Rodriguez-Perez PMCID: PMC2266907 Does the association of the triglyceride to high-density lipoprotein cholesterol ratio with fasting serum insulin differ by race/ethnicity? Chaoyang Li, Earl S Ford, Yuan-Xiang Meng, Ali H Mokdad, and Gerald M Reaven PMCID: PMC2292689 Association between the FTO rs9939609 polymorphism and the metabolic syndrome in a non-Caucasian multi-ethnic sample Salam A Al-Attar, Rebecca L Pollex, Matthew R Ban, T Kue Young, Peter Bjerregaard, Sonia S Anand, Salim Yusuf, Bernard Zinman, Stewart B Harris, Anthony JG Hanley, Philip W Connelly, Murray W Huff, and Robert A Hegele PMCID: PMC2275229 In vivo endothelial gene regulation in diabetes J Gregory Maresh and Ralph V Shohet PMCID: PMC2365940 Development and validation of a risk score for hospitalization for heart failure in patients with Type 2 Diabetes Mellitus Xilin Yang, Ronald C Ma, Wing-Yee So, Alice P Kong, Gary T Ko, Chun-Shun Ho, Christopher W Lam, Clive S Cockram, Peter C Tong, and Juliana C Chan PMCID: PMC2377240 Effect of the addition of rosiglitazone to metformin or sulfonylureas versus metformin/sulfonylurea combination therapy on ambulatory blood pressure in people with type 2 diabetes: A randomized controlled trial (the RECORD study) Michel Komajda, Paula Curtis, Markolf Hanefeld, Henning Beck-Nielsen, Stuart J Pocock, Andrew Zambanini, Nigel P Jones, Ramon Gomis, Philip D Home, and The RECORD Study Group PMCID: PMC2390513 Diabetic retinopathy is associated with pulse wave velocity, not with the augmentation index of pulse waveform Osamu Ogawa, Kiyoko Hiraoka, Takahiro Watanabe, Junichiro Kinoshita, Masahiko Kawasumi, Hidenori Yoshii, and Ryuzo Kawamori PMCID: PMC2377239 Exercise-induced expression of angiogenic growth factors in skeletal muscle and in capillaries of healthy and diabetic mice Riikka Kivelä, Mika Silvennoinen, Maarit Lehti, Sanni Jalava, Veikko Vihko, and Heikki Kainulainen PMCID: PMC2386864 Uteroplacental insufficiency down regulates insulin receptor and affects expression of key enzymes of long-chain fatty acid (LCFA) metabolism in skeletal muscle at birth Daniela Germani, Antonella Puglianiello, and Stefano Cianfarani PMCID: PMC2396605 Association between intrarenal arterial resistance and diastolic dysfunction in type 2 diabetes Richard J MacIsaac, Merlin C Thomas, Sianna Panagiotopoulos, Trudy J Smith, Huming Hao, D Geoffrey Matthews, George Jerums, Louise M Burrell, and Piyush M Srivastava PMCID: PMC2413205 Prospective randomized study for optimal insulin therapy in type 2 diabetic patients with secondary failure Yumi Miyashita, Rimei Nishimura, Masami Nemoto, Toru Matsudaira, Hideaki Kurata, Tamotsu Yokota, Kuninobu Yokota, Katsuyoshi Tojo, Kazunori Utsunomiya, and Naoko Tajima PMCID: PMC2442047 Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Alexander Tenenbaum, Valentina Boyko, Enrique Z Fisman, Ilan Goldenberg, Yehuda Adler, Micha S Feinberg, Michael Motro, David Tanne, Joseph Shemesh, Ehud Schwammenthal, and Solomon Behar PMCID: PMC2440374 Intensification of oxidative stress and inflammation in type 2 diabetes despite antihyperglycemic treatment Raymond Farah, Revital Shurtz-Swirski, and Olga Lapin PMCID: PMC2441608 First-line antihypertensive treatment in patients with pre-diabetes: Rationale, design and baseline results of the ADaPT investigation Walter Zidek, Joachim Schrader, Stephan Lüders, Stephan Matthaei, Christoph Hasslacher, Joachim Hoyer, Peter Bramlage, Claus-Dieter Sturm, and W Dieter Paar PMCID: PMC2529270 Interaction between Calpain 5, Peroxisome proliferator-activated receptor-gamma and Peroxisome proliferator-activated receptor-delta genes: a polygenic approach to obesity María E Sáez, Antonio Grilo, Francisco J Morón, Luis Manzano, María T Martínez-Larrad, Antonio González-Pérez, Javier Serrano-Hernando, Agustín Ruiz, Reposo Ramírez-Lorca, and Manuel Serrano-Ríos PMCID: PMC2527300 Evaluation of the cost effectiveness of exenatide versus insulin glargine in patients with sub-optimally controlled Type 2 diabetes in the United Kingdom Anette Woehl, Mark Evans, Anthony P Tetlow, and Philip McEwan PMCID: PMC2546382 Anaemia and kidney dysfunction in Caribbean Type 2 diabetic patients Chidum E Ezenwaka, Altheia Jones-LeCointe, Emeka Nwagbara, Dawn Seales, and Fidelis Okali PMCID: PMC2542986 Effect of streptozotocin-induced diabetes on myocardial blood flow reserve assessed by myocardial contrast echocardiography in rats Bernard Cosyns, Steven Droogmans, Sophie Hernot, Céline Degaillier, Christian Garbar, Caroline Weytjens, Bram Roosens, Danny Schoors, Tony Lahoutte, Philippe R Franken, and Guy Van Camp PMCID: PMC2546381 Metabolic syndrome according to different definitions in a rapidly developing country of the African region Clara Kelliny, Julita William, Walter Riesen, Fred Paccaud, and Pascal Bovet PMCID: PMC2556312 Prevalence of abnormal glucose metabolism in atrial fibrillation: A case control study in 75-year old subjects Odd Erik Johansen, Ellen Brustad, Steve Enger, and Arnljot Tveit PMCID: PMC2564913 Dyslipidemia in primary care – prevalence, recognition, treatment and control: data from the German Metabolic and Cardiovascular Risk Project (GEMCAS) Elisabeth Steinhagen-Thiessen, Peter Bramlage, Christian Lösch, Hans Hauner, Heribert Schunkert, Anja Vogt, Jürgen Wasem, Karl-Heinz Jöckel, and Susanne Moebus PMCID: PMC2572156 Improved survival in both men and women with diabetes between 1980 and 2004 – a cohort study in Sweden Mats Eliasson, Mats Talbäck, and Måns Rosén PMCID: PMC2586621 Polyol pathway and modulation of ischemia-reperfusion injury in Type 2 diabetic BBZ rat hearts Qing Li, Yuying C Hwang, Radha Ananthakrishnan, Peter J Oates, Dennis Guberski, and Ravichandran Ramasamy PMCID: PMC2584021 Exercise training enhanced myocardial endothelial nitric oxide synthase (eNOS) function in diabetic Goto-Kakizaki (GK) rats James Grijalva, Steven Hicks, Xiangmin Zhao, Sushma Medikayala, Pawel M Kaminski, Michael S Wolin, and John G Edwards PMCID: PMC2602993 Metabolic syndrome and risk of incident diabetes: findings from the European Prospective Investigation into Cancer and Nutrition-Potsdam Study Earl S Ford, Matthias B Schulze, Tobias Pischon, Manuela M Bergmann, Hans-Georg Joost, and Heiner Boeing PMCID: PMC2627822 Review The clinical relevance of assessing advanced glycation endproducts accumulation in diabetes Robbert Meerwaldt, Thera Links, Clark Zeebregts, Rene Tio, Jan-Luuk Hillebrands, and Andries Smit PMCID: PMC2569910 Study Protocol The impact of individualised cardiovascular disease (CVD) risk estimates and lifestyle advice on physical activity in individuals at high risk of CVD: a pilot 2 × 2 factorial understanding risk trial Hermione C Price, Lynne Tucker, Simon J Griffin, and Rury R Holman PMCID: PMC2490674 |
